• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

University of Chicago names Seenu Hariprasad University of Chicago chairman of Ophthalmology and Visual Science

Article

A vitreoretinal surgeon, Hariprasad joined the University of Chicago in 2005, and has been serving as interim chairman since 2020.

University of Chicago (Image Credit: AdobeStock/Jacob)

(Image Credit: AdobeStock/Jacob)

The University of Chicago has named Seenu M. Hariprasad, MD, the Shui-Chin Lee Professor of Ophthalmology, chairman of its Department of Ophthalmology and Visual Science, effective July 1, 2023.

Hariprasad has been interim chairman since 2020.

A vitreoretinal surgeon, Hariprasad joined the University of Chicago in 2005. During his career, he has developed a strong track record as a clinician, surgeon, researcher, educator, and leader in his department, according to the university news release, and has become a leading specialist in various vitreoretinal disorders, including macular degeneration, diabetic eye disease, intraocular infection, and retinal vein occlusions.

Seenu M. Hariprasad, MD (Image Credit: University of Chicago)

Seenu M. Hariprasad, MD (Image Credit: University of Chicago)

“He has implemented more effective and efficient sutureless microincisional vitrectomy techniques at the medical center, and his clinical research has contributed to the understanding and use of new medications to combat a wide variety of vitreoretinal disorders,” the university noted in the news release.

According to the university’s news release, Hariprasad has served as an investigator in more than 45 national and international retina clinical trials evaluating various medications, sustained drug-delivery devices, and surgical innovations. His work has led to more than 300 peer-reviewed publications, meeting abstracts and textbook chapters, including Management of Retinal Vein Occlusion: Current Concepts, which is among a small number of textbooks dedicated to this disease.

Related Videos
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.